Medium riskLarge capEducational sample dataset

Sun Pharmaceutical

SUNPHARMA · NSE & BSE · Pharmaceuticals · Pharma

Current price

₹1,750.00

+0.40%FY24 (illustrative)

Illustrative / demo price - not live.

Compare Learn this concept

About the company

India's largest pharmaceutical company by revenue, with a strong specialty portfolio.

Origin & history

Founded in 1983 by Dilip Shanghvi, it grew through acquisitions into India's largest drugmaker.

Founded

1983

Headquarters

Mumbai

Business segments

India Formulations34.0%
US Formulations30.0%
Emerging Markets20.0%
Other16.0%

Competitive position (moat)

Scale in generics, a strong specialty pipeline and a leading domestic brand.

Governance

Promoter-led with professional management; watch related-party and compliance.

Promoter holding

54.5%

Institutional holding

20.0%

Why it's interesting

A diversified pharma leader with a growing specialty business and a resilient domestic franchise.

What to verify

  • Specialty product ramp-up
  • US generic price erosion
  • Regulatory and compliance issues

Key risks

  • US pricing pressure
  • Regulatory actions
  • R&D execution

Valuation snapshot

Market cap

₹4.2 L cr

Total value of all shares: price multiplied by shares outstanding.

P/E

38.0

Price to earnings: how much you pay per rupee of profit.

P/B

5.0

Price to book: how the price compares to net asset value per share.

EV/EBITDA

22.0

Enterprise value to operating profit: a valuation that accounts for debt and cash.

Dividend yield

0.8%

Annual dividend per share as a percentage of the price.

Profitability

Revenue

₹49,000 cr

EBITDA

₹14,000 cr

Net income

₹11,000 cr

EPS

₹46.00

EBITDA margin

28.6%

Net margin

22.4%

ROE

15.0%

ROCE

16.0%

Revenue growth

9.0%

Balance sheet health

Debt/equity

0.1

Total debt divided by shareholders' equity: how leveraged the company is.

Cash

₹10,000 cr

Cash and equivalents on the balance sheet.

Interest coverage

12.0

How many times operating profit covers interest expense.

Dividends & returns

Dividend yield

0.8%

Dividend yield is the annual payout as a share of the price. A higher yield can signal a mature, cash-generative business - or a falling price. Check the payout history before reading too much into it.

Growth trend

Revenue growth

9.0%

Revenue growth shows how fast the top line is expanding. Pair it with margin trends to see whether growth is turning into profit.

Ownership

Promoter holding

54.5%

Share held by the founding family or group.

Institutional holding

20.0%

Share held by mutual funds, insurers and foreign institutions.

Placeholders - verify in the shareholding pattern.

Key catalysts

  • Specialty growth
  • US recovery

Red flags

  • Regulatory risk
  • US pricing

52-week range

52-week low

₹1,300.00

Lowest price in the 52-week range.

52-week high

₹1,800.00

Highest price in the 52-week range.